Identification of the human cytochromes P450 involved in the oxidative metabolism of “Ecstasy”-related designer drugs

This publication has 26 references indexed in Scilit:

• Recreational Use of “Ecstasy” (MDMA) Is Associated with Elevated Impulsivity
  Neuropsychopharmacology, 1998
• Adverse Reactions with 3,4-Methylenedioxymethamphetamine (MDMA; ???Ecstasy???)
  Drug Safety, 1996
• Adam and Eve make Love Analysis of the enantiomers of 3,4-methylenedioxy- N-ethylamphetamine (MDE, 'Eve') and its metabo lite 3,4-methylenedioxyamphetamine (MDA) in rat brain Hegadoren K, Baker G and Coutts R Journal of Pharmacological and Toxicological Methods 1995; 34: 117-123
  Human & Experimental Toxicology, 1996
• Pathology of deaths associated with "ecstasy" and "eve" misuse.
  Journal of Clinical Pathology, 1996
• Human cytochromes P450 expressed in Escherichia coli: production of specific antibodies
  Toxicology, 1996
• Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")
  The Lancet, 1992
• Ion trap tandem mass spectrometric evidence for the metabolism of 3,4-(methylenedioxy)methamphetamine to the potent neurotoxins 2,4,5-trihydroxymethamphetamine and 2,4,5-trihydroxyamphetamine
  Chemical Research in Toxicology, 1991
• Differences in induction of hepatic cytochrome p450 isozymes by mice in eight methylenedioxyphenyl compounds
  Journal of Biochemical Toxicology, 1990
• In vivo and in vitro metabolism of 3,4-(methylenedioxy)methamphetamine in the rat: identification of metabolites using an ion trap detector
  Chemical Research in Toxicology, 1988
• Absence of hepatic cytochrome P450bufI causes genetically deficient debrisoquine oxidation in man
  Biochemistry, 1988